Home > Insider Trading > Filing (0000899243-18-009614)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1574235	Pulmatrix Inc.	PULM	()	4

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1219039	Keith Crandell	C/O Arch Venture Fund Vii 8755 West Higgins Road, Suite 1025 Chicago IL 60631	No	No	No	Yes
1219042	Robert Nelsen	C/O Arch Venture Fund Vii 8755 West Higgins Road, Suite 1025 Chicago IL 60631	No	No	No	Yes
1219043	Clinton Bybee	C/O Arch Venture Fund Vii 8755 West Higgins Road, Suite 1025 Chicago IL 60631	No	No	No	Yes
1229592	Steven Gillis	8755 W Higgins, Suite 1025 Chicago IL 60631	Yes	No	No	No
1402439	Arch Venture Fund Vii Lp	8755 W Higgins, Suite 1025 Chicago IL 60631	No	No	No	Yes
1544443	Arch Venture Partners Vii, Llc	8755 W. Higgins Road Suite 1025 Chicago IL 60631	No	No	No	Yes
1544444	Arch Venture Partners Vii, L.p.	8755 W. Higgins Road Suite 1025 Chicago IL 60631	No	No	No	Yes

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-04-03	1,150,000	$0.00	3,436,456	No	4	P	Indirect	See Footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See Footnotes

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Warrant (right to buy)	Acquisiton	2018-04-03	1,150,000	$0.00	1,150,000	$0.65
Common Stock	Series B Warrant (right to buy)	Acquisiton	2018-04-03	1,150,000	$0.00	1,150,000	$0.75

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
1,150,000	2018-04-03	2018-10-03	No	4	P	Indirect
1,150,000	2018-04-03	2023-04-03	No	4	P	Indirect

Footnotes

The reported securities were included within 1,150,000 Units purchased by ARCH Venture Fund VII, L.P. ("ARCH VII") for $0.65 per Unit. Each Unit consisted of one share of common stock, one Series A Warrant to purchase one share of common stock at an exercise price of $0.65 per share, and one Series B Warrant to purchase one share of common stock at an exercise price of $0.75 per share.
Securities held of record byARCH VII. The sole general partner of ARCH VII is ARCH Venture Partners VII, L.P. ("ARCH Partners VII"), which may be deemed to have shared voting and investment power over the shares held by ARCH VII. The sole general partner of ARCH Partners VII is ARCH Venture Partners VII, LLC ("ARCH VII LLC"), which may be deemed to have shared voting and investment power over the shares held by ARCH VII. ARCH Partners VII and ARCH VII LLC disclaim beneficial ownership of such shares, except to the extent of any pecuniary interest therein.
The managing directors of ARCH VII LLC are Keith Crandell, Clinton Bybee and Robert Nelsen and they may be deemed to have shared voting and investment power over the shares held by ARCH VII. Dr. Steve Gillis owns an interest in ARCH Partners VII, but does not have dispositive or voting power. Messrs. Crandell, Bybee and Nelsen and Dr. Gillis disclaim beneficial ownership of such shares, except to the extent of any pecuniary interest therein.